DPH - 200 MA supportWe have seen price drop towards the 200 MA which acted as support. I would like to see price head back towards the 3000 price before looking to enter this stock. A break of the previous high with other key factors, i will be looking to enter this trade.
−607.02 MMXN
16.57 BMXN
110.25 M
About DECHRA PHARMACEUTICALS
Sector
CEO
Ian David Page
Headquarters
Northwich
Website
Employees (FY)
2.46 K
Founded
1997
ISIN
GB0009633180
Dechra Pharmaceuticals PLC is a holding company, which engages in the veterinary pharmaceuticals and related products business. It operates through the following segments: European Pharmaceuticals; North American Pharmaceuticals; and Pharmaceuticals Research and Development. The European Pharmaceuticals segment markets and sells licensed pharmaceuticals and specialist pet foods to the veterinary profession in Europe. The North American Pharmaceuticals segment focuses on the sale of a range of endocrine, ophthalmic, dermatological, and equine products in North America. The Pharmaceuticals Research and Development segment develops and licenses Dechra's own branded veterinary product portfolio of novel and generic pharmaceuticals and specialist pet diets. The company was founded in 1819 and is headquartered in Northwich, the United Kingdom.
Dechra Pharmaceuticals Fake-BreakoutLast post: June 3rd. See chart .
Review: Price was approaching the resistance level.
Update: Since the last post, price broke above the resistance level but has failed to stay there and has now fallen back below that level. The breakout was a fake breakout.
Conclusion: We need price to break th
Dechra Pharmaceuticals Looks Set To Breakout SoonLast post: Feb 28th. See chart .
Review: Price had broken a resistance level with a strong move to the upside.
Update: Price continued to trend higher but is now in a period of consolidation.
Conclusion: We will be waiting for a breakout of the resistance of the consolidation zone before consid
A UK STOCK MAKING NEW HIGHS!Dechra Pharmaceuticals LSE:DPH has been consistently growing since it launched on the UK Stock Market in 2000
where it opened around £1.25 and now currently stands at £25.
Although it has consistently risen ever since, the trend does contain deep pullbacks so if you decide to trade this stock
then
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of DPH/N is 858.69 MXN — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange DECHRA PHARMACEUTICALS stocks are traded under the ticker DPH/N.
DECHRA PHARMACEUTICALS is going to release the next earnings report on Sep 2, 2024. Keep track of upcoming events with our Earnings Calendar.
DPH/N stock is 0% volatile and has beta coefficient of 0.33. Check out the list of the most volatile stocks — is DECHRA PHARMACEUTICALS there?
DPH/N earnings for the last quarter are 11.21 MXN whereas the estimation was 11.03 MXN which accounts for 1.59% surprise. Estimated earnings for the next quarter are 14.63 MXN. See more details about DECHRA PHARMACEUTICALS earnings.
DECHRA PHARMACEUTICALS revenue for the last quarter amounts to 9.23 B MXN despite the estimated figure of 9.57 B MXN. In the next quarter revenue is expected to reach 8.23 B MXN.
Yes, you can track DECHRA PHARMACEUTICALS financials in yearly and quarterly reports right on TradingView.
Like other stocks, DPH/N shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DECHRA PHARMACEUTICALS stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 2.46 K employees. See our rating of the largest employees — is DECHRA PHARMACEUTICALS on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DECHRA PHARMACEUTICALS technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DECHRA PHARMACEUTICALS stock shows the sell signal. See more of DECHRA PHARMACEUTICALS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.